CLINICAL_TRIALS
research
· 2017-06-09
Clinical Trial Update: Prevalence of Secondary Cardiac Damage in Rheumatic Fever Patients and Penicillin Secondary Prophylaxis
Summary
The update examines the prevalence of secondary cardiac damage among rheumatic fever patients and the use of penicillin for secondary prophylaxis. The current t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assuta Hospital Systems | Conditions: Secondary Cardiac Damage in Rheumatic Fever | Status: UNKNOWN